196 related articles for article (PubMed ID: 6980181)
1. The effect of phorbol-myristate acetate and concanavalin A on the growth of interleukin-2-dependent T-cell lines.
Northoff H; Stoeck M; Krammer PH
Immunobiology; 1982 May; 161(5):464-75. PubMed ID: 6980181
[TBL] [Abstract][Full Text] [Related]
2. Activation of IL 1-dependent and IL 1-independent T cell lines by calcium ionophore and phorbol ester.
Zlotnik A; Daine B
J Immunol; 1986 Feb; 136(3):1033-7. PubMed ID: 3079793
[TBL] [Abstract][Full Text] [Related]
3. Studies on T-lymphocyte activation. I. Is competence inductions in thymocytes by phorbol myristate acetate, an accessory cell-independent event?
Diamantstein T; Klos M; Reimann J
Immunology; 1981 May; 43(1):183-9. PubMed ID: 6972903
[TBL] [Abstract][Full Text] [Related]
4. Influence of PMA on T-lymphocyte responses to mitogenic lymphokines.
Orosz CG; Roopenian DC
Lymphokine Res; 1984; 3(1):23-30. PubMed ID: 6332252
[TBL] [Abstract][Full Text] [Related]
5. Signals involved in T cell activation. I. Phorbol esters enhance responsiveness but cannot replace intact accessory cells in the induction of mitogen-stimulated T cell proliferation.
Davis L; Lipsky PE
J Immunol; 1985 Nov; 135(5):2946-52. PubMed ID: 3876369
[TBL] [Abstract][Full Text] [Related]
6. Phorbol myristate acetate-stimulated production of interleukin 2 by T-cell lymphoma and constitutive production by derived hybridomas.
Bubeník J; Indrová M; Símová J; Kypĕnová H; Bubeníková D; Dolezalová K
Neoplasma; 1984; 31(5):497-505. PubMed ID: 6334241
[TBL] [Abstract][Full Text] [Related]
7. Phorbol myristate acetate and in vitro T lymphocyte function. I. PMA may contaminate lymphokine preparations and can interfere with interleukin bioassays.
Orosz CG; Roopernian DC; Bach FH
J Immunol; 1983 Apr; 130(4):1764-9. PubMed ID: 6403611
[No Abstract] [Full Text] [Related]
8. Phorbol myristate acetate and in vitro T lymphocyte function. II. Influence of PMA and supernatants from PMA-treated P388D1 cells on the proliferation of cloned T cells.
Orosz CG; Roopenian DC; Bach FH
J Immunol; 1983 May; 130(5):2261-5. PubMed ID: 6220088
[TBL] [Abstract][Full Text] [Related]
9. Phorbol myristic acetate enhances the production of interleukin 2.
Fuller-Farrar J; Hilfiker ML; Farrar WL; Farrar JJ
Cell Immunol; 1981 Feb; 58(1):156-64. PubMed ID: 6784931
[No Abstract] [Full Text] [Related]
10. Effect of phorbol myristate acetate and a lymphokine on cyclic 3':5'-guanosine monophosphate levels and proliferation of macrophages.
Hadden EM; Sadlik JR; Coffey RG; Hadden JW
Cancer Res; 1982 Aug; 42(8):3064-9. PubMed ID: 6284356
[TBL] [Abstract][Full Text] [Related]
11. Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytes.
Borger P; Kauffman HF; Vijgen JL; Postma DS; Vellenga E
Exp Hematol; 1996 Feb; 24(2):108-15. PubMed ID: 8641331
[TBL] [Abstract][Full Text] [Related]
12. [Lymphokine production using IL-2-dependent human T-lymphocytes].
Stecher A; Mohr H; Schügerl K
Beitr Infusionther Klin Ernahr; 1987; 18():292-4. PubMed ID: 3125831
[No Abstract] [Full Text] [Related]
13. Early precursor thymocytes can produce interleukin 2 upon stimulation with calcium ionophore and phorbol ester.
Lugo JP; Krishnan SN; Sailor RD; Rothenberg EV
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1862-6. PubMed ID: 3081905
[TBL] [Abstract][Full Text] [Related]
14. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
Duncan MR; George FW; Hadden JW
J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
[TBL] [Abstract][Full Text] [Related]
15. Phorbol myristate acetate-protein complex mimics bioactivity of human IL-1. 1. Direct evidence that PMA temporarily enters and is released from cellular compartment during superinduction protocol.
Williams JM; Dinarello CA; Rosenwasser LJ; Kelley V; Reddish M; Strom TB
Lymphokine Res; 1985; 4(4):275-97. PubMed ID: 3876490
[TBL] [Abstract][Full Text] [Related]
16. [Artifactual interaction of PMA (phorbol myristate acetate) in the determination of interleuken 2 (IL 2) activity].
Mukaida N; Itoh Y; Kawai T; Hosoi J; Kasahara T; Nakano K
Rinsho Byori; 1984 Mar; 32(3):282-6. PubMed ID: 6610778
[No Abstract] [Full Text] [Related]
17. In vitro correction of the interleukin 2 defect of autoimmune mice.
Santoro TJ; Luger TA; Ravache ES; Smolen JS; Oppenheim JJ; Steinberg AD
Eur J Immunol; 1983 Jul; 13(7):601-4. PubMed ID: 6603367
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of interleukin-2 production from the cell activation in response to the mitogenic lectin in peripheral CD4+ T cells of LEC mutant rats.
Sakai T; Agui T; Muramatsu Y; Yamada T; Matsumoto K
Immunology; 1993 Jul; 79(3):491-7. PubMed ID: 8104885
[TBL] [Abstract][Full Text] [Related]
19. Comparison of phorbol myristate acetate and phytohaemagglutinin as stimulators of in vitro T lymphocyte colony formation of human peripheral blood lymphocytes. I. Surface markers of colony cells.
Suzawa T; Hyodo S; Kishi T; Kashiwa H; Karakawa T; Kittaka E; Sakano T; Usui T
Immunology; 1984 Nov; 53(3):499-505. PubMed ID: 6333386
[TBL] [Abstract][Full Text] [Related]
20. Cloned helper T lymphocytes exposed to interleukin 2 become unresponsive to antigen and concanavalin A but not to calcium ionophore and phorbol ester.
Otten G; Wilde DB; Prystowsky MB; Olshan JS; Rabin H; Henderson LE; Fitch FW
Eur J Immunol; 1986 Mar; 16(3):217-25. PubMed ID: 2937640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]